Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 262 of 1,261
  1. US 11344615

    Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in vero cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2022 · Expires May 26, 2042

    granted
  2. US 11345928

    Modified immunization vectors

    THE ARIZONA BOARD OF REGENTS · Granted May 31, 2022 · Expires May 26, 2042

    granted
  3. US 11345715

    Biologically active molecules, conjugates thereof, and therapeutic uses

    REGENERON PHARMACEUTICALS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  4. US 11344514

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  5. US 11345694

    Antibacterial compounds

    DISCUVA LIMITED · Granted May 31, 2022 · Expires May 26, 2042

    granted
  6. US 11345930

    Codon optimized RPGRORF15 genes and uses thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  7. US 11345904

    Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  8. US 11345734

    Chimeric T cell

    AUTOLUS LIMITED · Granted May 31, 2022 · Expires May 26, 2042

    granted
  9. US 11345733

    Colon and pancreas cancer specific antigens and antibodies

    PRECISION BIOLOGICS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  10. US 11345702

    PGDH inhibitors and methods of making and using

    Myoforte Therapeutics, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  11. US 11345705

    Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted May 31, 2022 · Expires May 26, 2042

    granted
  12. US 11345659

    Pipecolic esters for inhibition of the proteasome

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  13. US 11344707

    Devices for applying a topical treatment

    THERMA BRIGHT INC · Granted May 31, 2022 · Expires May 26, 2042

    granted
  14. US 11344631

    Promoter for cell-specific gene expression and uses thereof

    Universita' del Piemonte Orientale · Granted May 31, 2022 · Expires May 26, 2042

    granted
  15. US 11345658

    Compounds and compositions comprising the same for treating hypertension or heart failure

    QUANTUM GENOMICS · Granted May 31, 2022 · Expires May 26, 2042

    granted
  16. US 11344652

    Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted May 31, 2022 · Expires May 26, 2042

    granted
  17. US 11345653

    Compositions and methods for reactivating cholinesterases

    The Government of the United States, as represented by the Secretary of the Army · Granted May 31, 2022 · Expires May 26, 2042

    granted
  18. US 11344605

    Therapeutic use of inhibitors of t cell activation or stimulation

    HUMANITAS MIRASOLE S.P.A. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  19. US 11344581

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  20. US 11344618

    HIV envelope glycoprotein immunogens

    ACADEMISCH MEDISCH CENTRUM · Granted May 31, 2022 · Expires May 26, 2042

    granted
  21. US 11344610

    Prevention and reduction of blood loss

    Takeda Pharmaceutical Company Limited · Granted May 31, 2022 · Expires May 26, 2042

    granted
  22. US 11344609

    Compositions and methods for treating hemoglobinopathies

    Beam Therapeutics Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  23. US 11344579

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  24. US 11344578

    Immune cells expressing engineered antigen receptors

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.